Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics

Conference Article| August 01 1996 Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics K. S. Koblan; K. S. Koblan § *Department of Cancer Research, Merck Research Laboratories, West Point, PA 19486, U.S.A. §To whom correspondence should be addressed. Search for other works by this author on: This Site PubMed Google Scholar N. E. Kohl; N. E. Kohl *Department of Cancer Research, Merck Research Laboratories, West Point, PA 19486, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar C. A. Omer; C. A. Omer *Department of Cancer Research, Merck Research Laboratories, West Point, PA 19486, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar N. J. Anthony; N. J. Anthony †Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar M. W. Conner; M. W. Conner ‡Department of Safety Assessment, Merck Research Laboratories, West Point, PA 19486, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar S. J. de Solms; S. J. de Solms †Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar T. M. Williams; T. M. Williams †Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar S. L. Graham; S. L. Graham †Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar G. D. Hartman; G. D. Hartman †Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar A. Oliff; A. Oliff *Department of Cancer Research, Merck Research Laboratories, West Point, PA 19486, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar J. B. Gibbs J. B. Gibbs *Department of Cancer Research, Merck Research Laboratories, West Point, PA 19486, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar Biochem Soc Trans (1996) 24 (3): 688–692. https://doi.org/10.1042/bst0240688 Article history Received: March 20 1992 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Cite Icon Cite Get Permissions Citation K. S. Koblan, N. E. Kohl, C. A. Omer, N. J. Anthony, M. W. Conner, S. J. de Solms, T. M. Williams, S. L. Graham, G. D. Hartman, A. Oliff, J. B. Gibbs; Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics. Biochem Soc Trans 1 August 1996; 24 (3): 688–692. doi: https://doi.org/10.1042/bst0240688 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsBiochemical Society Transactions Search Advanced Search Keywords: FPP, farnesyl diphosphate, PFTase, protein farnesyltransferase, PGGTase-I, protein geranylgeranyltransferase I This content is only available as a PDF.